242 related articles for article (PubMed ID: 22943434)
1. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous recognition of HIV-1 TAR RNA bulge and loop sequences by cyclic peptide mimics of Tat protein.
Davidson A; Leeper TC; Athanassiou Z; Patora-Komisarska K; Karn J; Robinson JA; Varani G
Proc Natl Acad Sci U S A; 2009 Jul; 106(29):11931-6. PubMed ID: 19584251
[TBL] [Abstract][Full Text] [Related]
3. Co-crystal structures of HIV TAR RNA bound to lab-evolved proteins show key roles for arginine relevant to the design of cyclic peptide TAR inhibitors.
Chavali SS; Mali SM; Jenkins JL; Fasan R; Wedekind JE
J Biol Chem; 2020 Dec; 295(49):16470-16486. PubMed ID: 33051202
[TBL] [Abstract][Full Text] [Related]
4. A Cyclic Mimic of HIV Tat Differentiates Similar TAR RNAs on the Basis of Distinct Dynamic Behaviors.
Lu J; Nguyen L; Zhao L; Xia T; Qi X
Biochemistry; 2015 Jun; 54(23):3687-93. PubMed ID: 26016940
[TBL] [Abstract][Full Text] [Related]
5. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
Huq I; Rana TM
Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
[TBL] [Abstract][Full Text] [Related]
6. The structure of the human immunodeficiency virus type-1 TAR RNA reveals principles of RNA recognition by Tat protein.
Aboul-ela F; Karn J; Varani G
J Mol Biol; 1995 Oct; 253(2):313-32. PubMed ID: 7563092
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of both HIV-1 reverse transcription and gene expression by a cyclic peptide that binds the Tat-transactivating response element (TAR) RNA.
Lalonde MS; Lobritz MA; Ratcliff A; Chamanian M; Athanassiou Z; Tyagi M; Wong J; Robinson JA; Karn J; Varani G; Arts EJ
PLoS Pathog; 2011 May; 7(5):e1002038. PubMed ID: 21625572
[TBL] [Abstract][Full Text] [Related]
8. Molecular dynamics and MM/GBSA-integrated protocol probing the correlation between biological activities and binding free energies of HIV-1 TAR RNA inhibitors.
Peddi SR; Sivan SK; Manga V
J Biomol Struct Dyn; 2018 Feb; 36(2):486-503. PubMed ID: 28081678
[TBL] [Abstract][Full Text] [Related]
9. Orientation and affinity of HIV-1 Tat fragments in Tat-TAR complex determined by fluorescence resonance energy transfer.
Cao H; Tamilarasu N; Rana TM
Bioconjug Chem; 2006; 17(2):352-8. PubMed ID: 16536465
[TBL] [Abstract][Full Text] [Related]
10. Proximity of a Tat peptide to the HIV-1 TAR RNA loop region determined by site-specific photo-cross-linking.
Wang Z; Huq I; Rana TM
Bioconjug Chem; 1999; 10(3):512-9. PubMed ID: 10346885
[TBL] [Abstract][Full Text] [Related]
11. Essential structural requirements for specific recognition of HIV TAR RNA by peptide mimetics of Tat protein.
Davidson A; Patora-Komisarska K; Robinson JA; Varani G
Nucleic Acids Res; 2011 Jan; 39(1):248-56. PubMed ID: 20724442
[TBL] [Abstract][Full Text] [Related]
12. Interaction of human immunodeficiency virus type 1 Tat-derived peptides with TAR RNA.
Long KS; Crothers DM
Biochemistry; 1995 Jul; 34(27):8885-95. PubMed ID: 7612630
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the solution conformations of unbound and Tat peptide-bound forms of HIV-1 TAR RNA.
Long KS; Crothers DM
Biochemistry; 1999 Aug; 38(31):10059-69. PubMed ID: 10433713
[TBL] [Abstract][Full Text] [Related]
14. Discoveries of Tat-TAR interaction inhibitors for HIV-1.
Yang M
Curr Drug Targets Infect Disord; 2005 Dec; 5(4):433-44. PubMed ID: 16535863
[TBL] [Abstract][Full Text] [Related]
15. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat.
Taylor JP; Kundu M; Khalili K
Virology; 1993 Aug; 195(2):780-5. PubMed ID: 8337844
[TBL] [Abstract][Full Text] [Related]
16. Binding of neomycin to the TAR element of HIV-1 RNA induces dissociation of Tat protein by an allosteric mechanism.
Wang S; Huber PW; Cui M; Czarnik AW; Mei HY
Biochemistry; 1998 Apr; 37(16):5549-57. PubMed ID: 9548939
[TBL] [Abstract][Full Text] [Related]
17. Face-time with TAR: Portraits of an HIV-1 RNA with diverse modes of effector recognition relevant for drug discovery.
Chavali SS; Bonn-Breach R; Wedekind JE
J Biol Chem; 2019 Jun; 294(24):9326-9341. PubMed ID: 31080171
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen-bonding contacts in the major groove are required for human immunodeficiency virus type-1 tat protein recognition of TAR RNA.
Hamy F; Asseline U; Grasby J; Iwai S; Pritchard C; Slim G; Butler PJ; Karn J; Gait MJ
J Mol Biol; 1993 Mar; 230(1):111-23. PubMed ID: 8450529
[TBL] [Abstract][Full Text] [Related]
19. Tackling Tat.
Karn J
J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
